These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 14983807)
21. Experience with daptomycin in an infectious diseases service over 1 year: utility in an outpatient parenteral antibiotic programme. Seaton RA; Macconnachie AA Int J Antimicrob Agents; 2008 May; 31(5):492-7. PubMed ID: 18313274 [No Abstract] [Full Text] [Related]
22. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology. Wesson KM; Lerner DS; Silverberg NB; Weinberg JM Dis Mon; 2004 Jul; 50(7):395-406. PubMed ID: 15280870 [No Abstract] [Full Text] [Related]
23. [Daptomycin. Reassessment of an antibiotic]. Gobernado M Rev Esp Quimioter; 2007 Mar; 20(1):11-8. PubMed ID: 17530032 [No Abstract] [Full Text] [Related]
24. Therapeutic challenges in the era of antibiotic resistance. Lee C Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519 [TBL] [Abstract][Full Text] [Related]
25. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Kanafani ZA; Corey GR Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833 [TBL] [Abstract][Full Text] [Related]
28. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin. Owens RC; Lamp KC; Friedrich LV; Russo R Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950 [TBL] [Abstract][Full Text] [Related]
29. [The second life of daptomycin: analysis of a successful come-back]. Decousser JW; Doucet Populaire F Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200 [No Abstract] [Full Text] [Related]
31. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. Skiest DJ J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939 [TBL] [Abstract][Full Text] [Related]
32. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. French GL J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922 [TBL] [Abstract][Full Text] [Related]
33. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384 [TBL] [Abstract][Full Text] [Related]
34. [A new in star in antibiotic heaven--daptomycin]. Holzgrabe U Pharm Unserer Zeit; 2004; 33(4):270. PubMed ID: 15287683 [No Abstract] [Full Text] [Related]